199 related articles for article (PubMed ID: 20607844)
1. Mapping interactions of gastric inhibitory polypeptide with GIPR N-terminus using NMR and molecular dynamics simulations.
Tikhele SH; Pissurlenkar RR; Srivastava S; Saran A; Coutinho EC
J Pept Sci; 2010 Aug; 16(8):383-91. PubMed ID: 20607844
[TBL] [Abstract][Full Text] [Related]
2. Understanding interactions of gastric inhibitory polypeptide (GIP) with its G-protein coupled receptor through NMR and molecular modeling.
Malde AK; Srivastava SS; Coutinho EC
J Pept Sci; 2007 May; 13(5):287-300. PubMed ID: 17437246
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor.
Zhao F; Zhang C; Zhou Q; Hang K; Zou X; Chen Y; Wu F; Rao Q; Dai A; Yin W; Shen DD; Zhang Y; Xia T; Stevens RC; Xu HE; Yang D; Zhao L; Wang MW
Elife; 2021 Jul; 10():. PubMed ID: 34254582
[TBL] [Abstract][Full Text] [Related]
4. Conformational, receptor interaction and alanine scan studies of glucose-dependent insulinotropic polypeptide.
Venneti KC; Malthouse JP; O'Harte FP; Hewage CM
Biochim Biophys Acta; 2011 Jul; 1814(7):882-8. PubMed ID: 21539943
[TBL] [Abstract][Full Text] [Related]
5. Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand.
Yaqub T; Tikhonova IG; Lättig J; Magnan R; Laval M; Escrieut C; Boulègue C; Hewage C; Fourmy D
Mol Pharmacol; 2010 Apr; 77(4):547-58. PubMed ID: 20061446
[TBL] [Abstract][Full Text] [Related]
6. Investigating GIPR (ant)agonism: A structural analysis of GIP and its receptor.
Smit FX; van der Velden WJC; Kizilkaya HS; Nørskov A; Lückmann M; Hansen TN; Sparre-Ulrich AH; Qvotrup K; Frimurer TM; Rosenkilde MM
Structure; 2021 Jul; 29(7):679-693.e6. PubMed ID: 33891864
[TBL] [Abstract][Full Text] [Related]
7. Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.
Moon MJ; Kim HY; Kim SG; Park J; Choi DS; Hwang JI; Seong JY
Mol Cells; 2010 Aug; 30(2):149-54. PubMed ID: 20799012
[TBL] [Abstract][Full Text] [Related]
8. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
[TBL] [Abstract][Full Text] [Related]
9. Internalization and desensitization of the human glucose-dependent-insulinotropic receptor is affected by N-terminal acetylation of the agonist.
Ismail S; Dubois-Vedrenne I; Laval M; Tikhonova IG; D'Angelo R; Sanchez C; Clerc P; Gherardi MJ; Gigoux V; Magnan R; Fourmy D
Mol Cell Endocrinol; 2015 Oct; 414():202-15. PubMed ID: 26225752
[TBL] [Abstract][Full Text] [Related]
10. Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor.
Yuliantie E; van der Velden WJC; Labroska V; Dai A; Zhao F; Darbalaei S; Deganutti G; Xu T; Zhou Q; Yang D; Rosenkilde MM; Sexton PM; Wang MW; Wootten D
Biochem Pharmacol; 2021 Oct; 192():114715. PubMed ID: 34339714
[TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions of full-length and truncated GIP peptides with the GIP receptor - A comprehensive review.
Gabe MBN; van der Velden WJC; Smit FX; Gasbjerg LS; Rosenkilde MM
Peptides; 2020 Mar; 125():170224. PubMed ID: 31809770
[TBL] [Abstract][Full Text] [Related]
13. The bioactive conformation of glucose-dependent insulinotropic polypeptide by NMR and CD spectroscopy.
Alaña I; Malthouse JP; O'Harte FP; Hewage CM
Proteins; 2007 Jul; 68(1):92-9. PubMed ID: 17393464
[TBL] [Abstract][Full Text] [Related]
14. NMR structure of the glucose-dependent insulinotropic polypeptide fragment, GIP(1-30)amide.
Alaña I; Hewage CM; Malthouse JP; Parker JC; Gault VA; O'Harte FP
Biochem Biophys Res Commun; 2004 Dec; 325(1):281-6. PubMed ID: 15522230
[TBL] [Abstract][Full Text] [Related]
15. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
16. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
[TBL] [Abstract][Full Text] [Related]
17. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
[TBL] [Abstract][Full Text] [Related]
18. Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission Tomography.
Eriksson O; Velikyan I; Haack T; Bossart M; Evers A; Lorenz K; Laitinen I; Larsen PJ; Plettenburg O; Johansson L; Pierrou S; Wagner M
Diabetes; 2021 Apr; 70(4):842-853. PubMed ID: 33547046
[TBL] [Abstract][Full Text] [Related]
19. Functional elements of the gastric inhibitory polypeptide receptor: Comparison between secretin- and rhodopsin-like G protein-coupled receptors.
Cordomí A; Ismail S; Matsoukas MT; Escrieut C; Gherardi MJ; Pardo L; Fourmy D
Biochem Pharmacol; 2015 Aug; 96(3):237-46. PubMed ID: 26043830
[TBL] [Abstract][Full Text] [Related]
20. The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of
Regazzo D; Losa M; Albiger NM; Terreni MR; Vazza G; Ceccato F; Emanuelli E; Denaro L; Scaroni C; Occhi G
Eur J Endocrinol; 2017 May; 176(5):543-553. PubMed ID: 28179449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
